Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Earnings Deliver a Buy and a Sell

By

As earnings continue to roll out, the news has generated enough infomation to spark a sell for one stock and boost enthusiasm for another.

PrintPRINT

A large majority of earnings reports from all sectors were bad, and while my firm's were generally better, some of them disappointed as well.

I won't sell a stock for having a bad quarter or because I don't like the market, but if I have specific reasons that give me pause aside from those, that may tip the balance. That is the case with Avon Products (NYSE:AVP).

I did not and do not expect a quick turnaround at Avon, and I expected the recent dividend cut. That's why it wasn't in the High Income Portfolio, despite its stated 6.8% yield. Those factors didn't influence this choice. I also still expect the company to come back, despite all its problems.

The new CEO, Sherilyn S. McCoy, certainly has credentials. She has a Master's Degree in chemical engineering from Princeton, an MBA from Rutgers, and previously handled the marketing for Johnson & Johnson's (NYSE:JNJ) skin care division.

That said, after this quarter, the company is dangerously close to blowing some loan covenants, and while I have no doubt they'll be granted waivers, given Avon's assets, I'd rather take our 6.6% loss and have the cash in this climate.

I wouldn't procrastinate on this. The stock is significantly below its high for the year, so we will probably see pretty heavy tax selling over the next month or so.

Moreover, with the overall earnings climate negative, there should be bargains aplenty sometime in December after a possible post-election rally subsides. We can probably deploy this money in a company with stronger, clearer prospects, while keeping an eye on Avon for possible reinvestment later.

Meanwhile, Companhia de Bebidas das Americas (NYSE:ABV) had spectacular earnings: up 48.2%, or 80 cents per share, versus 54 cents for the third quarter of 2011. Net sales rose 26.1% including acquisitions, and 15.1% just on an organic growth basis.

My enthusiasm is somewhat tempered by the fact that unit volume growth didn't match sales growth. That indicates that the latter was helped by price increases, which are not as sustainable as unit growth. Still, the company is performing well, and so is the stock.

We're starting to see an economic rebound on ABV's main turf in Brazil, and other parts of its domain have held up pretty well all through the recent sluggish period. We have a nice 9.3% gain since February to hold us through any rough patch we may face in the next few quarters, although I suspect it won't be as bad down there as it is up north.

Ambev (NYSE:BUD) is another stock I'm hoping to add to on any significant pullback.

Editor's Note: This article was written by Jack Adamo of Insiders Plus.

Below, find some more great investing and trading content from MoneyShow:

The Medical Device Pacesetter

The Benefits of Growth Investing

3D Printers Score Big Gains

Twitter: @TopProsTopPicks
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE